Will Big Pharma Acquire Novavax?

Novavax is a vaccine specialist, and the demand for vaccines has increased dramatically because of COVID-19. This virus has done trillions of dollars' worth of economic damage and has killed at least a million people worldwide. Most of humanity is going to need to be vaccinated, and governments are already paying billions to make that happen.

Let's look at why a major pharmaceutical company might want to acquire Novavax.